RNA News

Latest RNA News

• Moderna (MRNA) Receives a Hold from UBS
  TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
• Moderna Stock Faces Dilution Risk and Downward Pressure From Convertible Note Conversions
  TipRanks Auto-Generated Newsdesk · Nov 8, 2026
• Polymarket Odds: Will MRNA, HUM, UAA Beat Earnings Tomorrow?
  Eddie Pan · Nov 5, 2026
• Moderna Advances Testing of Updated COVID-19 Vaccines as Investors Await Results
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
• Moderna Updates Early-Stage EBV Vaccine Study: What MRNA Investors Should Watch
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
• The Week That Was, The Week Ahead: Macro and Markets, November 1
  Ran Melamed · Nov 1, 2026
• Moderna’s Next‑Gen Pediatric Covid Shot Enters Key Phase 2 Test: What Investors Should Watch
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 29, 2026
• Moderna’s Next Flu Move: New Pediatric mRNA-1010 Trial Targets Long-Term Vaccine Growth
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
• RBC Capital Sticks to Their Hold Rating for Moderna (MRNA)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
• Moderna (MRNA) Receives a Hold from Evercore ISI
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
• Moderna’s Cancer Vaccine Earns Praise from Doctors amid Stock Selloff
  Vince Condarcuri · Oct 23, 2026
• Moderna’s Norovirus Vaccine Trial Reaches Key Milestone, Supporting Its Post-COVID Growth Story
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 23, 2026
• Alterity Therapeutics Issues New Unlisted Employee Options
  TipRanks Australian Auto-Generated Newsdesk · Oct 22, 2026
• Alterity Therapeutics Grants New Unlisted Employee Options
  TipRanks Australian Auto-Generated Newsdesk · Oct 22, 2026
• Moderna Stock Is Crashing Over 20%: What Spooked Investors and What Wall Street Sees Next
  Ben Yoffe · Oct 22, 2026
• Moderna Stock (MRNA) Plunges 25% as Data Is Leaked Online
  Joel Baglole · Oct 22, 2026
• Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Moderna (MRNA) and Abbott Laboratories (ABT)
  TipRanks Newsroom · Oct 22, 2026
• RBC Capital Remains a Hold on Moderna (MRNA)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
• RBC Capital Remains a Hold on Moderna (MRNA)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
• Eterna Therapeutics Updates Investor Presentation and Disclosures
  TipRanks Auto-Generated Newsdesk · Oct 15, 2026